Chromadex Corp
NASDAQ:CDXC
Chromadex Corp
NASDAQ:CDXC
Price:
3.78 USD
0.53%
Market Closed
Updated:
May 5, 2024
Chromadex Corp
Operating Expenses
|
Chromadex Corp
Operating Expenses Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Chromadex Corp
NASDAQ:CDXC
|
Operating Expenses
-$56.4m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-22%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Operating Expenses
-$9.8B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-10%
|
|
|
Danaher Corp
NYSE:DHR
|
Operating Expenses
-$16.1B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-10%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Operating Expenses
-$1.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Operating Expenses
-$2.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Operating Expenses
-$3.2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-14%
|
See Also
What is Chromadex Corp's Operating Expenses?
Operating Expenses
-56.4m
USD
-56.4m
USD
Based on the financial report for Dec 31, 2023, Chromadex Corp's Operating Expenses amounts to -56.4m USD.
What is Chromadex Corp's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-22%
-22%
Over the last year, the Operating Expenses growth was 8%. The average annual Operating Expenses growth rates for Chromadex Corp have been -1% over the past three years , -3% over the past five years , and -22% over the past ten years .
You don't have any saved screeners yet
